Furthermore, recessive mutations in exon 15 of FXR1 can lead to congenital multi‐minicore myopathy in both humans and mice.[26] Therefore, exploring the different functions of gene isoforms is significant because, for the treatment of certain diseases, partial inhibitors may provide a safer pharmacological profile compared to full inhibitors by having distinct potencies for different isoforms.[62]. The gene discussed is FXR1; the disease is myopathy.